• Biosysen will hold an extraordinary general meeting in Wanchai, Hong Kong on Aug. 25, 2026.
• Shareholders will vote on increasing authorized share capital to HK$ 100 million from HK$ 20 million.
• The proposal would raise the authorized share count to 10 billion shares from 2 billion, creating 8 billion new shares with HK$ 0.01 par value.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosysen Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260805-12272111), on August 04, 2026, and is solely responsible for the information contained therein.